Digital Therapeutics (DTx)

“Digital Health” continues to evolve quickly, with technological innovations providing new opportunities for patients, providers, and payers. Despite the clear opportunity to improve health through digitally-enabled interventions, it remains challenging to achieve commercial success for digital products. Key challenges include securing favorable market access and reimbursement, incorporating digital tools into provider workflows, and optimizing the patient experience.

Informed by decades of experience developing go-to-market strategies for health technologies (pharma, biotech, MedTech, DTx, etc.), our team brings deep expertise in value demonstration, access and reimbursement, pricing, demand generation, and business model development to overcome the uptake and payment hurdles facing emerging digital technologies.

Our focus areas


  • 01
    Market access strategy for a device/App combination in diabetes
    CRA approach Conducted a thorough market access landscape analysis in six countries covering reimbursement, pricing, purchasing, access pathways, and evidence...
    View engagement
  • 02
    Five-year vision in prescription digital therapeutics
    CRA approach Facilitated a two-day strategic workshop with client’s leadership team to debate and align on “what company should be” vs. “what company should...
    View engagement
  • 03
    Value proposition reimbursement pathways for a DTx
    CRA approach Evaluated relevant eHealth analogues to establish the likely reimbursement and funding pathways for a novel eHealth product. Determined PMA...
    View engagement

Related capabilities

Subscribe to receive our latest Insights.